Chemoinformaics analysis of (2e,6e,8e)-n-(2-Methylpropyl)-2,6,8-decatrienamide
Molecular Weight | 221.344 | nRot | 7 |
Heavy Atom Molecular Weight | 198.16 | nRig | 4 |
Exact Molecular Weight | 221.178 | nRing | 0 |
Solubility: LogS | -2.379 | nHRing | 0 |
Solubility: LogP | 2.15 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 40.6182 |
nHD | 1 | BPOL | 24.5118 |
QED | 0.519 |
Synth | 2.927 |
Natural Product Likeliness | 1.09 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.361 |
MDCK | 0.0000836 |
BBB | 0.722 |
PPB | 0.864519 |
VDSS | 1.092 |
FU | 0.160754 |
CYP1A2-inh | 0.848 |
CYP1A2-sub | 0.406 |
CYP2c19-inh | 0.829 |
CYP2c19-sub | 0.728 |
CYP2c9-inh | 0.323 |
CYP2c9-sub | 0.979 |
CYP2d6-inh | 0.395 |
CYP2d6-sub | 0.898 |
CYP3a4-inh | 0.303 |
CYP3a4-sub | 0.179 |
CL | 8.659 |
T12 | 0.778 |
hERG | 0.035 |
Ames | 0.426 |
ROA | 0.02 |
SkinSen | 0.927 |
Carcinogencity | 0.156 |
EI | 0.896 |
Respiratory | 0.307 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.752427 |